The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Role of ERBB signaling in RET-rearranged lung cancer and contribution of EGFR amplification to cabozantinib resistance.
 
Roger Smith
Stock and Other Ownership Interests - Pacific Biosciences
 
Alexander E. Drilon
Honoraria - AstraZeneca; Blueprint Medicines; Exelixis; Genentech/Roche; Ignyta; Loxo
Consulting or Advisory Role - ARIAD
Research Funding - Foundation Medicine
 
Siddharth Kunte
No Relationships to Disclose
 
Ken Suzawa
No Relationships to Disclose
 
Takuo Hayashi
No Relationships to Disclose
 
Lukas Delasos
No Relationships to Disclose
 
Huichun Tai
No Relationships to Disclose
 
Tyler Hitchman
No Relationships to Disclose
 
Inna Khodos
No Relationships to Disclose
 
Marissa Mattar
No Relationships to Disclose
 
Shinji Kohsaka
No Relationships to Disclose
 
Elisa de Stanchina
No Relationships to Disclose
 
William Lockwood
No Relationships to Disclose
 
Marc Ladanyi
Honoraria - Merck (I)
Consulting or Advisory Role - NCCN/AstraZeneca; NCCN/Boehringer Ingelheim
Research Funding - Loxo (Inst)
 
Romel Somwar
No Relationships to Disclose